PSMA-targeting fluorescent imaging agent IS-002
Term · Oncology and biomedicine · MLC-T-ONC-016286
A near-infrared (NIR) fluorescent imaging agent targeting the tumor-associated antigen (TAA) prostate-specific membrane antigen (PSMA), that can potentially be used as a tumor-selective fluorescent imaging agent during NIR fluorescence imaging-guided surgery. Upon intravenous administration, the PSMA-targeting fluorescent imaging agent IS-002 targets and binds to PSMA on PSMA-expressing tumor cells. Upon fluorescent imaging, PSMA-expressing tumors can be visualized and identified, and surgically removed. PSMA is overexpressed by most prostate cancers.
| Identifier | MLC-T-ONC-016286 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | fluorophore IS-002; PSMA-targeted fluorescent imaging agent IS-002 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016286",
"term": "PSMA-targeting fluorescent imaging agent IS-002",
"field": "Oncology and biomedicine",
"definition": "A near-infrared (NIR) fluorescent imaging agent targeting the tumor-associated antigen (TAA) prostate-specific membrane antigen (PSMA), that can potentially be used as a tumor-selective fluorescent imaging agent during NIR fluorescence imaging-guided surgery. Upon intravenous administration, the PSMA-targeting fluorescent imaging agent IS-002 targets and binds to PSMA on PSMA-expressing tumor cells. Upon fluorescent imaging, PSMA-expressing tumors can be visualized and identified, and surgically removed. PSMA is overexpressed by most prostate cancers.",
"synonyms": [
"fluorophore IS-002",
"PSMA-targeted fluorescent imaging agent IS-002"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/psma-targeting-fluorescent-imaging-agent-is-002/"
}
Record 13,820 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.